Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines.

MLA

Bilyeu, Jennifer D., et al. “Circumvention of Nuclear Factor KappaB-Induced Chemoresistance by Cytoplasmic-Targeted Anthracyclines.” Molecular Pharmacology, vol. 65, no. 4, Apr. 2004, pp. 1038–47. EBSCOhost, https://doi.org/10.1124/mol.65.4.1038.

APA

Bilyeu, J. D., Panta, G. R., Cavin, L. G., Barrett, C. M., Turner, E. J., Sweatman, T. W., Israel, M., Lothstein, L., & Arsura, M. (2004). Circumvention of nuclear factor kappaB-induced chemoresistance by cytoplasmic-targeted anthracyclines. Molecular Pharmacology, 65(4), 1038–1047. https://doi.org/10.1124/mol.65.4.1038

Chicago

Bilyeu, Jennifer D, Ganesh R Panta, Lakita G Cavin, Christina M Barrett, Eddie J Turner, Trevor W Sweatman, Mervyn Israel, Leonard Lothstein, and Marcello Arsura. 2004. “Circumvention of Nuclear Factor KappaB-Induced Chemoresistance by Cytoplasmic-Targeted Anthracyclines.” Molecular Pharmacology 65 (4): 1038–47. doi:10.1124/mol.65.4.1038.